SciELO - Scientific Electronic Library Online

 
vol.130 número8Portación de Staphylococcus aureus enterotoxigénicos en manipuladores de alimentosHemorragia digestiva baja masiva: resultados del estudio y el tratamiento quirúrgico en 20 pacientes consecutivos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

ALVO A, Miriam; ELGUETA S, Leticia; ARAGON V, Henry  y  COTERA F, Alejandro. Use of intravenous iron without erythropoietin for the treatment of anemia of hemodialysis. Rev. méd. Chile [online]. 2002, vol.130, n.8, pp.865-868. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872002000800004.

Background: In the last two decades, the use of erythropoietin for the correction of anemia in hemodialysis patients has been recommended. In Chile, only 10% of hemodialysis patients use erythropoietin, therefore, the correction of iron deficiency must be optimized. Aim: To report the effects of intravenous iron without erythropoietin in the management of anemia in hemodialysis patients. Material and methods: Retrospective analysis of 42 patients that received intravenous ferrous sacarate in doses of 100 mg/week during 5 weeks and 100 mg bimonthly during six months. These patients did not receive erythropoietin. Results. Thirty six patients had iron deficiency. Basal ferritin was 137±22 µg/l and increased to 321±28 µg/l after treatment. Packed red cell volume increased from 24±2% to 29±3%. No adverse effects were reported. Conclusions: Iron deficiency is frequent in hemodialyzed patients. Intravenous iron is safe and effective in the treatment of iron deficiency in these patients (Rev Méd Chile 2002; 130: 865-8)

Palabras clave : Anemia, iron-deficiency; Erythropoietin; Hemodialysis; Iron compunds.

        · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons